What is Letermovir: Uses, Dosage, Side Effects and More

Letermovir is an antiviral medication that helps prevent cytomegalovirus (CMV) infections in people who have received stem cell transplants. CMV is a common virus that can cause serious complications in people with weakened immune systems, especially those recovering from transplant procedures.

This medication works differently from other antiviral drugs and represents a newer approach to preventing CMV-related health problems. Understanding how letermovir works and what to expect can help you feel more confident about your treatment plan.

What is Letermovir?

Letermovir belongs to a class of medications called CMV terminase complex inhibitors. It's specifically designed to prevent cytomegalovirus from multiplying in your body after you've had a stem cell transplant.

The medication targets a specific part of the CMV virus called the terminase complex, which the virus needs to reproduce. By blocking this process, letermovir helps keep CMV under control when your immune system is still recovering from transplant treatments.

Unlike some other antiviral medications, letermovir is generally well-tolerated and doesn't typically cause the kidney problems that can occur with other CMV prevention drugs. This makes it a valuable option for many transplant patients.

What is Letermovir Used For?

Letermovir is primarily used to prevent CMV infection and disease in adults who have received an allogeneic hematopoietic stem cell transplant and are at risk for CMV infection. This type of transplant uses stem cells from a donor to replace your bone marrow.

After a stem cell transplant, your immune system becomes significantly weakened while it recovers. During this vulnerable period, CMV can reactivate if you've been exposed to it before, or you might catch it from your donor's cells. CMV can cause serious complications including pneumonia, liver problems, and digestive issues.

Your doctor will typically prescribe letermovir if you're CMV-positive (meaning you've been exposed to CMV before) or if your donor was CMV-positive. The medication serves as a protective shield while your new immune system develops and strengthens.

How Does Letermovir Work?

Letermovir works by targeting a specific enzyme complex that CMV needs to package its genetic material and create new virus particles. Think of it as blocking a crucial step in the virus's reproduction process.

The medication is considered moderately strong and highly specific to CMV, meaning it doesn't interfere with other viruses or your body's normal cellular processes. This targeted approach helps reduce the risk of side effects compared to broader-spectrum antiviral medications.

Once you take letermovir, it gets absorbed into your bloodstream and travels throughout your body, creating a protective barrier against CMV multiplication. The medication maintains effective levels in your system for about 24 hours, which is why it's typically taken once daily.

How Should I Take Letermovir?

Take letermovir exactly as your doctor prescribes, usually once daily at the same time each day. You can take it with or without food, but taking it with food may help reduce any stomach upset you might experience.

Swallow the tablets whole with a glass of water. Don't crush, break, or chew the tablets, as this can affect how the medication is absorbed in your body. If you have trouble swallowing pills, talk to your healthcare team about alternatives.

Try to establish a routine by taking letermovir at the same time every day. This helps maintain steady levels of the medication in your system and makes it easier to remember your dose. Many patients find it helpful to link taking their medication with a daily activity like eating breakfast or brushing their teeth.

How Long Should I Take Letermovir For?

Most patients take letermovir for about 100 days after their stem cell transplant, though your doctor may adjust this timeframe based on your specific situation. The medication is typically started within the first few days after your transplant procedure.

Your healthcare team will monitor your CMV levels through regular blood tests during treatment. These tests help determine whether the medication is working effectively and when it might be safe to stop taking it.

Don't stop taking letermovir on your own, even if you're feeling well. Your immune system needs time to recover fully, and stopping the medication too early could leave you vulnerable to CMV infection. Your doctor will let you know when it's appropriate to discontinue the medication based on your lab results and overall recovery progress.

What Are the Side Effects of Letermovir?

Like all medications, letermovir can cause side effects, though many people tolerate it well. The most common side effects are generally mild and manageable with proper support from your healthcare team.

Here are the side effects you might experience, starting with the most common ones:

• Nausea and occasional vomiting
• Diarrhea or loose stools
• Fatigue or feeling more tired than usual
• Headache
• Abdominal pain or discomfort
• Swelling in your legs, ankles, or feet
• Muscle spasms or cramps

Most of these side effects are mild and tend to improve as your body adjusts to the medication. Your healthcare team can provide strategies to help manage these symptoms effectively.

Some less common but more serious side effects can occur, though they're relatively rare. These might include significant changes in your heart rhythm, severe allergic reactions, or unusual changes in your blood counts.

Contact your healthcare provider right away if you experience chest pain, rapid or irregular heartbeat, severe dizziness, difficulty breathing, or signs of an allergic reaction like rash, swelling, or severe itching.

Who Should Not Take Letermovir?

Letermovir isn't suitable for everyone, and your doctor will carefully evaluate whether it's the right choice for your situation. People with certain medical conditions or those taking specific medications may need alternative treatments.

You should not take letermovir if you're allergic to the medication or any of its ingredients. Tell your doctor about any previous allergic reactions to medications, especially antiviral drugs.

Your doctor will also consider letermovir carefully if you have moderate to severe liver problems, as the medication is processed through your liver. They may need to adjust your dose or choose a different treatment approach.

Certain medications can interact with letermovir, potentially affecting how well it works or increasing your risk of side effects. Be sure to tell your healthcare team about all medications, supplements, and herbal products you're taking.

Letermovir Brand Names

Letermovir is available under the brand name Prevymis in the United States and many other countries. This is the most commonly prescribed form of the medication.

The medication is manufactured by Merck & Co. and is available in both oral tablet and intravenous (IV) formulations. Your doctor will determine which form is most appropriate for your situation.

Generic versions of letermovir are not yet widely available, so you'll likely receive the brand-name medication. Your insurance coverage and pharmacy benefits will determine your out-of-pocket costs for the medication.

Letermovir Alternatives

If letermovir isn't suitable for you, several other medications can help prevent CMV infections after stem cell transplant. Your doctor will choose the best alternative based on your specific medical situation and risk factors.

Valganciclovir is another commonly used CMV prevention medication, though it may cause more side effects, particularly affecting your blood counts and kidney function. Some patients may need regular blood tests to monitor for these effects.

Ganciclovir (given intravenously) is another option, especially for patients who can't take oral medications. Acyclovir or valacyclovir might be used in some situations, though they're generally less effective against CMV than the other options.

Your healthcare team will work with you to find the most appropriate CMV prevention strategy based on your transplant type, overall health, and individual risk factors.

Is Letermovir Better Than Valganciclovir?

Both letermovir and valganciclovir are effective at preventing CMV infections, but they have different advantages and considerations. The "better" choice depends on your individual circumstances and health profile.

Letermovir generally causes fewer serious side effects, particularly regarding blood counts and kidney function. This makes it a good option for patients who might be at higher risk for these complications.

Valganciclovir has been used longer and has extensive research supporting its effectiveness, but it requires more frequent blood monitoring due to its potential effects on your white blood cells and kidney function.

Your doctor will consider factors like your kidney function, blood counts, other medications you're taking, and your specific transplant situation when choosing between these options. Both medications have proven effective in clinical studies.